Ingles Markets Inc
F:IN3A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ingles Markets Inc
F:IN3A
|
US |
|
C
|
Cyren Ltd
F:TOU
|
IL |
|
S
|
SDI Group PLC
XBER:SD0
|
UK |
|
T
|
Takara Leben Co Ltd
F:TDI
|
JP |
|
J
|
Jindal Poly Films Ltd
BSE:500227
|
IN |
|
T
|
Territorial Bancorp Inc
F:9TB
|
US |
|
N
|
Nektar Therapeutics
F:ITH
|
US |
|
K
|
Kestrel Gold Inc
OTC:KSTBF
|
CA |
|
EC World Real Estate Investment Trust
OTC:ECWDF
|
SG |
|
Quoin Pharmaceuticals Ltd
F:2EB0
|
IL |
|
B
|
Bio Rad Laboratories Inc
F:BUWA
|
US |
|
X
|
XXL ASA
F:2XX
|
NO |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IN3A's stock price target?
Not Available
IN3A does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Ingles Markets Inc?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 6 years is -3%.